SKN | Enliven Therapeutics Surges as Investors Bet on Cancer Drug Development Pipeline
Enliven Therapeutics, Inc. (NASDAQ: ELVN) attracted significant investor attention after its shares surged more than 14% in a single trading session, closing at $46.13...
SKN | ProShares Trust Advances ETF Expansion Strategy as Demand for Thematic Investment Products Accelerates
ProShares Trust is preparing for a new market offering that underscores the continued expansion of exchange-traded funds as a core vehicle for modern portfolio...
SKN | RF Industries Approaches Earnings With Growth Momentum and Network Infrastructure Opportunities in Focus
RF Industries, Ltd. (NASDAQ: RFIL) is preparing to report fiscal second-quarter earnings as investors evaluate whether the company can continue building on its recent...
SKN | Global IPO Weekly Review (June 8–June 12, 2026): US Mega IPOs and Biotech Strength Offset Limited Activity Across Europe and Asia
Key Points
Large US IPOs shift institutional capital toward technology, biotechnology, and acquisition vehicles, reinforcing the United States as the dominant global fundraising market.
...
SKN | Alumis Gains Momentum as Autoimmune Drug Developer Advances Late-Stage Pipeline
Alumis Inc. (NASDAQ: ALMS) attracted strong investor attention after its shares climbed more than 15% in a single trading session, pushing the biotechnology company's...